2.44
+0.06(+2.52%)
Currency In USD
| Previous Close | 2.38 |
| Open | 2.38 |
| Day High | 2.46 |
| Day Low | 2.37 |
| 52-Week High | 10.79 |
| 52-Week Low | 2.36 |
| Volume | 710,137 |
| Average Volume | 721,830 |
| Market Cap | 153.47M |
| PE | -3.05 |
| EPS | -0.8 |
| Moving Average 50 Days | 4.21 |
| Moving Average 200 Days | 6.06 |
| Change | 0.06 |
If you invested $1000 in Treace Medical Concepts, Inc. (TMCI) since IPO date, it would be worth $95.57 as of December 24, 2025 at a share price of $2.44. Whereas If you bought $1000 worth of Treace Medical Concepts, Inc. (TMCI) shares 3 years ago, it would be worth $104.86 as of December 24, 2025 at a share price of $2.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Treace Medical Secures Up to $175 Million in Debt Financing
GlobeNewswire Inc.
Dec 18, 2025 1:30 PM GMT
New 5-Year Agreement Provides Continued Financial Strength & FlexibilityPONTE VEDRA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamen
Treace Announces Participation in Two Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 07, 2025 1:05 PM GMT
PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
GlobeNewswire Inc.
Oct 23, 2025 8:05 PM GMT
PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor